Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart rhythm study probes why some patients tolerate VT better than others

NCT ID NCT05841199

First seen Apr 05, 2026 · Last updated Jun 22, 2026 · Updated 13 times

Summary

This observational study at Imperial College London will enroll 70 people undergoing heart catheterization to understand why some patients tolerate ventricular tachycardia (VT) better than others. Researchers will measure blood pressure and blood flow in the heart during simulated fast heart rates. The goal is to see how coronary artery disease and stents affect VT tolerability.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Imperial College NHS Foundation Trust

    RECRUITING

    London, W12 0HS, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors better predict which patients are at risk from dangerous heart rhythms and guide treatment decisions.

What could go wrong

This is an observational study, not a treatment trial. It will not directly test a new therapy, and results may not change current practice immediately.

Conditions

The condition(s) this trial relates to.

coronary artery disorder coronary microvascular disorder heart failure Microvascular Angina ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.